Last reviewed · How we verify
Magic Mouthwash — Competitive Intelligence Brief
phase 3
Topical oral rinse combination therapy
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Magic Mouthwash (Magic Mouthwash) — Vanderbilt-Ingram Cancer Center. Magic Mouthwash is a topical oral rinse that combines local anesthetics, antimicrobials, and anti-inflammatory agents to relieve oral mucositis pain and promote healing in cancer patients.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Magic Mouthwash TARGET | Magic Mouthwash | Vanderbilt-Ingram Cancer Center | phase 3 | Topical oral rinse combination therapy |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical oral rinse combination therapy class)
- Vanderbilt-Ingram Cancer Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Magic Mouthwash CI watch — RSS
- Magic Mouthwash CI watch — Atom
- Magic Mouthwash CI watch — JSON
- Magic Mouthwash alone — RSS
- Whole Topical oral rinse combination therapy class — RSS
Cite this brief
Drug Landscape (2026). Magic Mouthwash — Competitive Intelligence Brief. https://druglandscape.com/ci/magic-mouthwash. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing